Middle East and Africa Respiratory Diagnostics Market – Industry Trends and Forecast to 2030

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Middle East and Africa Respiratory Diagnostics Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Reports
  • Feb 2023
  • MEA
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Middle East And Africa Respiratory Diagnostics Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2030
Diagramm Marktgröße (Basisjahr)
USD 1,441.70 Million
Diagramm Marktgröße (Prognosejahr)
USD 3,045.75 Million
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Middle East and Africa Respiratory Diagnostics Market, By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other) – Industry Trends and Forecast to 2030.

Middle East and Africa Respiratory Diagnostics Market

Middle East and Africa Respiratory Diagnostics Market Analysis and Size

The Middle East and Africa region is largely affected because of the burden of chronic diseases which increases the adoption of respiratory diagnostics. According to the 2021 report from the International Diabetes Federation (IDF), 24 million adults (20-79) are living with diabetes in the IDF Africa Region. The growing burden of diabetes is leading to the market expansion in a major way. The increasing incidence of respiratory diseases has set a huge concern for accurate disease diagnosis and hence increased the growth of the respiratory diagnostics market.

Data Bridge Market Research analyses a growth rate in the respiratory diagnostics market in the forecast period 2023-2030. The expected CAGR of respiratory diagnostics market is tend to be around 9.8% in the mentioned forecast period. The market was valued at USD 1441.7 million in 2022, and it would grow upto USD 3045.75 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Middle East and Africa Respiratory Diagnostics Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Product & Services (Instruments and Devices, Assays and Reagents and Services and Software), Test Type (Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests and Molecular Diagnostic Tests), Diseases (Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Asthma, Tuberculosis, Bronchitis, Pulmonary Fibrosis and Other Diseases), End User (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories and Other End Users), Distribution Channel (Direct Tender, Retail Sales and Other)

Countries Covered

Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA)

Market Players Covered

BD (U.S.), COSMED srl (Italy), Abbott (U.S.), NIHON KOHDEN CORPORATION (Japan), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), MGC Diagnostics Corporation (U.S.), Masimo (U.S.), bioMérieux SA (France), Carestream Health  (U.S.), VYAIRE (U.S.), Seegene Inc. (South Korea) and ResMed (U.S.)

Market Opportunities

  • Increased Elderly Population
  • Growing Product Launches and Collaborations

Market Definition

Respiratory diagnostics are the type of medical products and technologies that are widely used to diagnose the respiratory diseases and disorders in the patients. Respiratory diagnostics are effective since it can diagnose the diseases at an early stage. It involve procedures such as computed tomography, spirometry, oximetry, chest X- ray, transcutaneous carbon dioxide monitoring, sniff nasal inspiratory pressure (SNIP) among several other types.

Middle East and Africa Respiratory Diagnostics Market Dynamics

Drivers

  • Growing Rate of Pneumonia

The increasing prevalence of pneumonia is driving the market growth at a fast pace. Pneumonia is the top cause of morbidity and death in under-five children. It was expected that pneumonia kills around 900,000 under-five children each year globally. Around 172 deaths per 1,000 live births occur in sub-Saharan African countries, with pneumonia being the major cause. Thus, this increasing prevalence demands increased diagnostics which boost the market growth.

  • Higher Demand of Hospitals

The growing demand of hospitals helps in increasing the market growth rapidly. Most respiratory disease diagnostics are primarily carried out in hospitals since they are very complex in nature and it requires technologically advanced products and therefore this is boosting the market for hospital or clinical laboratories. Thus, this factor boosts the market growth.

Opportunities

  • Increased Elderly Population

The growing number of ageing population and their associated comorbid conditions such as deteriorating respiratory conditions, cough issues, community-acquired pneumonia, nonpneumonic respiratory tract infection and acute exacerbation of chronic obstructive pulmonary disease tend to create opportunities for the wide use of these diagnostics. It has been witnessed in the study of the IDF Diabetes Atlas, 10th edition, published in 2021, an expected 24 million adults aged 20-79 years were living with diabetes in the Africa region, having a regional prevalence of 4.5%. Furthermore, around 54% of people living with diabetes in the region are left undiagnosed. Thus, all these factors boost the market growth.

  • Growing Product Launches and Collaborations

Numerous product launches, partnership and agreement are initiated by many companies globally, which are also increasing the respiratory diagnostics market. For instance, Abbott launched Panbio COVID-19 Rapid Test in France in September 2020 for supporting the detection of rapidly increasing COVID-19 patients in France. The company became in higher demand after the launch of this diagnostic test. Thus, these kinds of launches associated with the respiratory diagnostics boost the market growth.

Restraints/Challenges

  • High Cost of Diagnostic Instruments

The increased expenditure required for the installation of these instruments hamper the market growth. Many of the diagnostic equipment are very high in cost, becoming unaffordable for many underdeveloped countries. Numerous market players make huge investments in installing new and advanced machines to increase the process and in return the cost is increased. Thus, this factor hamper the market growth.

This Middle East and Africa respiratory diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Middle East and Africa respiratory diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Middle East and Africa Respiratory Diagnostics Market Scope

The Middle East and Africa respiratory diagnostics market is segmented on the basis of product and services, test type, diseases, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

  • Instruments and Devices
  • Assays and Reagents
  • Services and Software

Test Type

  • Traditional Diagnostic Tests
  • Mechanical Tests
  • Imaging Tests
  • Molecular Diagnostic Tests

Diseases

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Asthma
  • Tuberculosis
  • Bronchitis
  • Pulmonary Fibrosis
  • Other Diseases

End User

  • Hospital/Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Others

Distribution Channel

  • Direct Tender
  • Retail Sales
  • Other

 Middle East and Africa Respiratory Diagnostics Market Regional Analysis/Insights

The Middle East and Africa respiratory diagnostics market is analyzed and market size insights and trends are provided by product and services, test type, diseases, end-user and distribution channel as referenced above.

The major countries covered in the respiratory diagnostics market report are Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Saudi Arabia is leading the market growth because of the growing focus on the high incidence of the disorders among old elderly population. The increasing social media concerns are also acting as major growth factors for the market. Moreover, several companies are advancing their diagnosis products by using new techniques to obtain target-specific and accurate results which is boosting the growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The respiratory diagnostics also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for respiratory diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the respiratory diagnostics market. The data is available for historic period 2011-2021.

Competitive Landscape and Middle East and Africa Respiratory Diagnostics Market Share Analysis

The respiratory diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Middle East and Africa respiratory diagnostics market.

Key players operating in the Middle East and Africa respiratory diagnostics market include:

  • BD (U.S.)
  • COSMED srl (Italy)
  • Abbott (U.S.)
  • NIHON KOHDEN CORPORATION (Japan)
  • Drägerwerk AG & Co. KGaA (Germany)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • GENERAL ELECTRIC COMPANY (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Medtronic (Ireland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • MGC Diagnostics Corporation (U.S.)
  • Masimo (U.S.)
  • bioMérieux SA (France)
  • Carestream Health  (U.S.)
  • VYAIRE (U.S.)
  • Seegene Inc.(South Korea)
  • ResMed (U.S.)


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The Middle East and Africa respiratory diagnostics market size will be worth USD 3045.75 million by 2030.
The growth rate of the Middle East and Africa respiratory diagnostics market is 9.8% during the forecast period by 2030.
Growing rate of pneumonia & higher demand of hospitals are the growth drivers of the Middle East and Africa respiratory diagnostics market.
Product and services, test type, diseases, end-user and distribution channel are the factors on which the Middle East and Africa respiratory diagnostics market research is based.
Major companies in the Middle East and Africa respiratory diagnostics market are BD (U.S.), COSMED srl (Italy), Abbott (U.S.), NIHON KOHDEN CORPORATION (Japan), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), MGC Diagnostics Corporation (U.S.), Masimo (U.S.), bioMérieux SA (France), Carestream Health (U.S.), VYAIRE (U.S.), Seegene Inc. (South Korea) and ResMed (U.S.).